Walgreens
6
29M
3
0.05
1
0.50
- Areas of investment
Summary
Walgreens appeared to be the Corporate Investor, which was created in 1901. The main department of described Corporate Investor is located in the Deerfield. The company was established in North America in United States.
The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Theranos, TytoCare, MedAvail. Among the most popular fund investment industries, there are Consumer, Health Care.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 0 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2014.
The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Walgreens, startups are often financed by Teuza, OrbiMed, LionBird. The meaningful sponsors for the fund in investment in the same round are OrbiMed, LionBird, Fosun Group. In the next rounds fund is usually obtained by OrbiMed, LionBird, ITOCHU Corporation.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Rounds per year
- 0.05
- Follow on index
- 0.50
- Investments by industry
- Health Care (6)
- Health Diagnostics (5)
- mHealth (3)
- Diagnostic Equipment (3)
- Medical Device (3) Show 9 more
- Investments by region
-
- United States (5)
- Canada (1)
- Peak activity year
- 2014
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 3B
- Group Appearance index
- 0.67
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
TytoCare | 14 Jul 2015 | Diagnostic Equipment, Other Healthcare Technology Systems, Software, Artificial Intelligence, Machine Learning, Health Care, Health Diagnostics, Medical Device, mHealth | Early Stage Venture | 12M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.